搜索结果: 'methocult media formulations for human hematopoietic cells serum containing'

Troubleshooting Guide for STEMdiff™ Cardiomyocyte Kits

Nature Research Round Table: Maintenance of Human Pluripotent Stem Cells In Vitro Dr. Tenneille Ludwig from the WiCell Research Institute provides information on in vitro culture systems for ES and iPS cell maintenance. The WiCell Research Institute is widely known for their human pluripotent stem cell (hPSC) banking services, with over 1,350 cell lines available to researchers around the globe. This presentation and the following Q&A session were moderated by Dr. Ludovic Vallier from the Wellcome Trust Sanger Institute.

This presentation was part of a Round Table series titled “Challenges in Ensuring hPSC Quality”, hosted in partnership with Nature Research. Global experts gathered at the Springer Nature headquarters in London, UK, to tackle some of the most pertinent issues impacting the use of human pluripotent stem cells (hPSCs), ranging from fundamental biology research to therapeutic applications. Explore the full series here.

Human Primary Cells

DNase I Treatment for Clumpy Cell Suspensions To reduce cell clumping and minimize presence of free-floating DNA fragments, we recommend adding DNase I Solution (Catalog #07900) to the cell suspension

Tips & Techniques for Highly Enriched Mouse MSC Cultures As Early As Passage 0 .

2018-2019 Hematopoietic Training Catalog

Enzyme-Free Passaging of Human Embryonic and Induced Pluripotent Stem Cells .

Using Cell Density Gradients to Optimize Your Cell Isolations RosetteSep™, a unique immunodensity cell isolation platform, isolates highly purified cells by density gradient centrifugation without columns or magnets

Nature Research Round Table: Genomic Integrity of Human Pluripotent Stem Cells Dr. Martin Pera from the Jackson Laboratory and International Stem Cell Initiative (ISCI) discusses the biological effects of recurrent genetic variants that arise in human pluripotent stem cells (hPSCs) in culture and during differentiation. This presentation and the following Q&A session were moderated by Dr. Peter Andrews from the University of Sheffield.

This presentation was part of a Round Table series titled “Challenges in Ensuring hPSC Quality”, hosted in partnership with Nature Research. Global experts gathered at the Springer Nature headquarters in London, UK, to tackle some of the most pertinent issues impacting the use of human pluripotent stem cells (hPSCs), ranging from fundamental biology research to therapeutic applications. Explore the full series here.

Note: Some original data from this presentation has been omitted to abide by copyright rules.

Nature Research Round Table: Genome Editing in Human Pluripotent Stem Cells Dr. Ludovic Vallier from the Wellcome Trust Sanger Institute discusses considerations for genome editing in human pluripotent stem cells (hPSCs). Dr. Vallier is involved at the Cambridge Biomedical Research Center Core Facility, whose services include providing genome-edited iPS cell lines for disease modeling and developing approaches for cell-based therapies. This presentation and the following Q&A session were moderated by Dr. Alex Alderton from the Wellcome Trust Sanger Institute.

This presentation was part of a Round Table series titled “Challenges in Ensuring hPSC Quality”, hosted in partnership with Nature Research. Global experts gathered at the Springer Nature headquarters in London, UK, to tackle some of the most pertinent issues impacting the use of human pluripotent stem cells (hPSCs), ranging from fundamental biology research to therapeutic applications. Explore the full series here.

Note: Some original data from this presentation has been omitted to abide by copyright rules.

Genome Editing of Human Primary T Cells Using CRISPR-Cas9

Depletion of Red Blood Cells from Small Cord Blood Samples .